Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 27 studies | 27% ± 9% | |
classical monocyte | 20 studies | 24% ± 9% | |
astrocyte | 14 studies | 35% ± 16% | |
endothelial cell of lymphatic vessel | 12 studies | 22% ± 6% | |
monocyte | 10 studies | 24% ± 7% | |
microglial cell | 10 studies | 27% ± 10% | |
glutamatergic neuron | 9 studies | 45% ± 20% | |
myeloid cell | 9 studies | 34% ± 9% | |
alveolar macrophage | 6 studies | 29% ± 10% | |
dendritic cell | 5 studies | 24% ± 10% | |
oligodendrocyte | 5 studies | 24% ± 6% | |
conventional dendritic cell | 4 studies | 31% ± 9% | |
GABAergic neuron | 4 studies | 39% ± 14% | |
interneuron | 4 studies | 31% ± 15% | |
neutrophil | 3 studies | 22% ± 8% | |
neuron | 3 studies | 34% ± 8% | |
mononuclear phagocyte | 3 studies | 25% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 34% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 16718.06 | 2640 / 2642 | 100% | 179.49 | 704 / 705 |
skin | 100% | 5092.49 | 1804 / 1809 | 99% | 194.57 | 467 / 472 |
adrenal gland | 100% | 7073.32 | 258 / 258 | 90% | 57.60 | 207 / 230 |
kidney | 99% | 4639.71 | 88 / 89 | 91% | 127.63 | 818 / 901 |
breast | 100% | 7898.31 | 459 / 459 | 87% | 41.58 | 971 / 1118 |
lung | 100% | 7649.08 | 576 / 578 | 86% | 44.10 | 996 / 1155 |
liver | 95% | 5300.97 | 214 / 226 | 81% | 42.10 | 327 / 406 |
ovary | 98% | 3421.34 | 177 / 180 | 71% | 30.21 | 306 / 430 |
uterus | 96% | 3212.19 | 163 / 170 | 71% | 31.42 | 328 / 459 |
esophagus | 83% | 2511.48 | 1199 / 1445 | 83% | 49.03 | 151 / 183 |
intestine | 88% | 2834.95 | 849 / 966 | 58% | 23.66 | 308 / 527 |
prostate | 91% | 2985.69 | 224 / 245 | 38% | 9.54 | 193 / 502 |
bladder | 76% | 2894.90 | 16 / 21 | 53% | 25.39 | 266 / 504 |
thymus | 80% | 2247.71 | 524 / 653 | 45% | 13.51 | 275 / 605 |
stomach | 44% | 1399.16 | 159 / 359 | 76% | 35.10 | 217 / 286 |
pancreas | 32% | 791.08 | 106 / 328 | 87% | 43.11 | 155 / 178 |
adipose | 100% | 8005.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 220.60 | 80 / 80 |
spleen | 99% | 5266.95 | 239 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 71.77 | 27 / 29 |
blood vessel | 85% | 3023.55 | 1134 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 37.63 | 37 / 45 |
heart | 82% | 3039.12 | 702 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 13979.48 | 754 / 929 | 0% | 0 | 0 / 0 |
muscle | 51% | 1417.53 | 411 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050870 | Biological process | positive regulation of T cell activation |
GO_0010468 | Biological process | regulation of gene expression |
GO_0032680 | Biological process | regulation of tumor necrosis factor production |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0071650 | Biological process | negative regulation of chemokine (C-C motif) ligand 5 production |
GO_0032649 | Biological process | regulation of type II interferon production |
GO_0045428 | Biological process | regulation of nitric oxide biosynthetic process |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
GO_0007155 | Biological process | cell adhesion |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0050765 | Biological process | negative regulation of phagocytosis |
GO_1903720 | Biological process | negative regulation of I-kappaB phosphorylation |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0032651 | Biological process | regulation of interleukin-1 beta production |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0032688 | Biological process | negative regulation of interferon-beta production |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0032675 | Biological process | regulation of interleukin-6 production |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0071349 | Biological process | cellular response to interleukin-12 |
GO_0071641 | Biological process | negative regulation of macrophage inflammatory protein 1 alpha production |
GO_0016477 | Biological process | cell migration |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0035696 | Biological process | monocyte extravasation |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009986 | Cellular component | cell surface |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0086080 | Molecular function | protein binding involved in heterotypic cell-cell adhesion |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0030695 | Molecular function | GTPase regulator activity |
GO_1990405 | Molecular function | protein antigen binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | SIRPA |
Protein name | Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a) |
Synonyms | SHPS1 MFR BIT PTPNS1 MYD1 SIRP |
Description | FUNCTION: Immunoglobulin-like cell surface receptor for CD47. Acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. Supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. May play a key role in intracellular signaling during synaptogenesis and in synaptic function (By similarity). Involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin. Mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. Plays a role in antiviral immunity and limits new world arenavirus infection by decreasing virus internalization (By similarity). Receptor for THBS1 . Interaction with THBS1 stimulates phosphorylation of SIRPA (By similarity). In response to THBS1, involved in ROS signaling in non-phagocytic cells, stimulating NADPH oxidase-derived ROS production . . |
Accessions | ENST00000400068.7 [P78324-1] ENST00000356025.7 [P78324-1] P78324 ENST00000358771.5 [P78324-1] ENST00000622179.4 [P78324-2] |